Raymond Goodrich

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology.

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage.

Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology.

Comparison of computerized formulae for determination of platelet recovery and survival.

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.

Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.

Functional inactivation of white blood cells by Mirasol treatment.

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants.

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

Reduction of prion infectivity in packed red blood cells.

Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.

Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.

Defining "adequate" pathogen reduction performance for transfused blood components.

In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.

White blood cell inactivation after treatment with riboflavin and ultraviolet light.

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.

Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function.

Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions.

Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.

Improving blood safety and patient outcomes with pathogen reduction technology.

Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.

Preparation of cryoprecipitate from riboflavin and UV light-treated plasma.

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system.

Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications.

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection.

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia.

Development of a riboflavin and ultraviolet light-based device to treat whole blood.

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.

Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice.

Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.

Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.

Chemical and biological mechanisms of pathogen reduction technologies.

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.

Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.

Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.